Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHA
3001
Chagee Holdings Limited American Depositary Shares
CHA
$3.09B
| $845K | ﹤0.01% |
+32,367
| New | +$845K |
|
3002
Emerald Holding
EEX
$980M
| $842K | ﹤0.01% |
173,639
-172,778
| -50% | -$838K |
|
3003
Protagonist Therapeutics
PTGX
$3.66B
| $840K | ﹤0.01% |
15,191
-119,078
| -89% | -$6.58M |
|
3004
Biomea Fusion
BMEA
$115M
| $839K | ﹤0.01% |
465,958
+184,219
| +65% | +$332K |
|
3005
The RealReal
REAL
$1.09B
| $838K | ﹤0.01% |
174,926
-708,764
| -80% | -$3.39M |
|
3006
TFS Financial
TFSL
$3.75B
| $835K | ﹤0.01% |
64,457
+23,897
| +59% | +$309K |
|
3007
Bluerock Homes Trust
BHM
$49.9M
| $834K | ﹤0.01% |
66,645
+1,558
| +2% | +$19.5K |
|
3008
Taylor Devices
TAYD
$149M
| $832K | ﹤0.01% |
+19,170
| New | +$832K |
|
3009
Werner Enterprises
WERN
$1.68B
| $832K | ﹤0.01% |
30,395
-66,380
| -69% | -$1.82M |
|
3010
Viridian Therapeutics
VRDN
$1.54B
| $831K | ﹤0.01% |
59,436
-238,530
| -80% | -$3.33M |
|
3011
Merus
MRUS
$5.26B
| $831K | ﹤0.01% |
15,796
-570,638
| -97% | -$30M |
|
3012
The Oncology Institute
TOI
$285M
| $830K | ﹤0.01% |
+405,009
| New | +$830K |
|
3013
Zura Bio
ZURA
$130M
| $829K | ﹤0.01% |
789,309
+485,736
| +160% | +$510K |
|
3014
Moody's
MCO
$91.9B
| $826K | ﹤0.01% |
1,647
-177,006
| -99% | -$88.8M |
|
3015
Energizer
ENR
$2.02B
| $825K | ﹤0.01% |
40,917
-23,482
| -36% | -$473K |
|
3016
1stdibs.com
DIBS
$101M
| $823K | ﹤0.01% |
299,452
+188,069
| +169% | +$517K |
|
3017
iQIYI
IQ
$2.51B
| $819K | ﹤0.01% |
462,791
-6,491,922
| -93% | -$11.5M |
|
3018
Beazer Homes USA
BZH
$781M
| $818K | ﹤0.01% |
+36,576
| New | +$818K |
|
3019
Clearfield
CLFD
$453M
| $814K | ﹤0.01% |
+18,756
| New | +$814K |
|
3020
Hooker Furnishings Corp
HOFT
$111M
| $813K | ﹤0.01% |
+76,875
| New | +$813K |
|
3021
Innovative Solutions & Support
ISSC
$197M
| $812K | ﹤0.01% |
58,510
-49,372
| -46% | -$685K |
|
3022
Virco
VIRC
$126M
| $809K | ﹤0.01% |
101,326
-96,876
| -49% | -$773K |
|
3023
Omeros
OMER
$282M
| $808K | ﹤0.01% |
269,421
-45,831
| -15% | -$137K |
|
3024
Jasper Therapeutics
JSPR
$39.5M
| $806K | ﹤0.01% |
145,219
+119,280
| +460% | +$662K |
|
3025
ProShares Ultra QQQ
QLD
$9.34B
| $806K | ﹤0.01% |
+6,844
| New | +$806K |
|